Can chronic kidney disease (CKD) cause hepatorenal syndrome (HRS) in patients with advanced liver disease, particularly cirrhosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can CKD Cause Hepatorenal Syndrome?

No, chronic kidney disease (CKD) does not cause hepatorenal syndrome (HRS)—rather, advanced cirrhosis with portal hypertension causes HRS, and CKD can coexist as a separate comorbidity in patients with liver disease. 1

Understanding the Directional Relationship

HRS is fundamentally a complication of advanced liver disease, not kidney disease:

  • HRS develops from cirrhosis-induced hemodynamic changes: The primary pathophysiology involves splanchnic and systemic vasodilation from portal hypertension, leading to effective arterial underfilling, compensatory activation of vasoconstrictor systems (renin-angiotensin-aldosterone and sympathetic nervous systems), and ultimately severe renal vasoconstriction. 1, 2

  • The liver disease drives the kidney dysfunction: HRS occurs in the setting of preserved tubular function and absence of significant histologic kidney abnormalities—it is a functional, potentially reversible form of acute kidney injury triggered by the cirrhotic state. 3, 4

  • CKD is an independent comorbidity, not a cause: CKD is becoming increasingly prevalent in patients with cirrhosis, particularly those with metabolic syndrome, diabetes, and NASH, but this represents concurrent structural kidney disease rather than a causal pathway to HRS. 1

The Complex Overlap of CKD and HRS

The clinical challenge lies in distinguishing HRS-AKI superimposed on pre-existing CKD:

  • CKD affects nearly half of patients with cirrhosis, especially those with NASH, diabetes, and metabolic syndrome. 1

  • When HRS develops in a patient with underlying CKD, attributing further kidney injury becomes challenging—it's difficult to separate acute functional deterioration from HRS versus chronic progressive structural damage from the underlying CKD. 1

  • Management remains the same: If HRS is suspected in a patient with CKD, treatment should follow standard HRS algorithms with vasoconstrictors and albumin while awaiting better markers of tubular damage. 1

Key Diagnostic Criteria for HRS

HRS diagnosis requires all of the following, confirming it originates from liver disease, not kidney disease 2, 5:

  • Cirrhosis with ascites
  • AKI defined by International Club of Ascites criteria (Stage 1: creatinine increase ≥0.3 mg/dL or 1.5-2x baseline; Stage 2: 2-3x baseline; Stage 3: >3x baseline or >4 mg/dL with acute increase ≥0.3 mg/dL) 2
  • No improvement after 2 consecutive days of diuretic withdrawal and plasma volume expansion with albumin 1 g/kg body weight 2, 5
  • Absence of shock 2
  • No current or recent nephrotoxic drug use 2
  • Absence of structural kidney injury (no proteinuria >500 mg/day, no microhematuria >50 RBCs/HPF, normal renal ultrasound) 2

Common Clinical Pitfalls

Do not confuse the direction of causality:

  • Patients with primary kidney disease (CKD) who later develop cirrhosis still develop HRS from the liver disease, not from their pre-existing CKD. 1

  • The presence of CKD does not prevent HRS from occurring—it simply makes diagnosis more complex and prognosis worse. 1

  • For liver transplant candidates with CKD: If measured GFR is below 30 ml/min, combined liver-kidney transplantation rather than liver transplantation alone should be considered. 1

Precipitating Factors for HRS (Not Causes)

HRS is precipitated by factors that worsen the hemodynamic derangements of cirrhosis 1, 2:

  • Bacterial infections (especially spontaneous bacterial peritonitis)—HRS develops in approximately 30% of patients with SBP 2, 6
  • Volume depletion from aggressive diuretics or large-volume paracentesis without albumin 2
  • Gastrointestinal bleeding 2
  • Any acute deterioration in liver function 2

These are triggers, not causes—the underlying cause remains the cirrhotic liver disease itself. 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria for Hepatorenal Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Hepatorenal syndrome: Current concepts and future perspectives.

Clinical and molecular hepatology, 2023

Research

Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2012

Guideline

Management of Hepatorenal Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Hepatorenal Syndrome Predictors and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.